Photofrin
Payments companies reported to CMS as associated with Photofrin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Photofrin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Photofrin
These are the largest totals companies reported as associated with Photofrin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jonathan Kurman | Milwaukee, WI | Pulmonary Disease | $21,471.54 |
| Wilson Tsai | Walnut Creek, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $19,125.94 |
| George Cheng | San Diego, CA | Pulmonary Disease | $15,951.06 |
| Omar Awais | Pittsburgh, PA | $15,579.82 | |
| Amit Tandon | Wesley Chapel, FL | Critical Care Medicine (Internal Medicine) | $14,093.72 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $12,160.23 |
| Kamran Ayub | Oak Lawn, IL | Gastroenterology (Internal Medicine) | $11,660.05 |
| Momen Wahidi | Chicago, IL | Pulmonary Disease | $11,424.44 |
| Septimiu Murgu | Chicago, IL | Pulmonary Disease | $10,800.91 |
| Justin Watson | Madison, WI | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $9,183.21 |
Prescribed Photofrin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.